Mercaptopurine
Mercaptopurine is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including Mercaptopurine. Available dosage forms: tablet, powder.
Drug Details
- Generic Name
- Mercaptopurine
- Brand Names
- Mercaptopurine
- Application Number
- ANDA040528
- Sponsor
- Golden State Medical Supply, Inc.
- NDC Codes
- 4
- Dosage Forms
- TABLET, POWDER
- Routes
- ORAL
- Active Ingredients
- MERCAPTOPURINE
Indications and Usage
1 INDICATIONS AND USAGE Mercaptopurine Tablets is a nucleoside metabolic inhibitor indicated for treatment of adult and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen. (1.1) 1.1 Acute Lymphoblastic Leukemia Mercaptopurine Tablets are indicated for treatment of adult and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.